399 related articles for article (PubMed ID: 21555862)
1. Urodynamic parameters development and complications of clean intermittent self-catheterization in Chinese schoolchildren with neurogenic underactive bladder.
Wang QW; Song DK; Zhang XP; Wu YD; Zhang RL; Wei JX; Wen JG
Urol Int; 2011; 86(4):461-5. PubMed ID: 21555862
[TBL] [Abstract][Full Text] [Related]
2. Detrusor overactivity in spina bifida: how long does it need to be treated?
Ab E; Dik P; Klijn AJ; van Gool JD; de Jong TP
Neurourol Urodyn; 2004; 23(7):685-8. PubMed ID: 15382196
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for febrile urinary tract infection in children with myelodysplasia treated by clean intermittent catheterization.
Seki N; Masuda K; Kinukawa N; Senoh K; Naito S
Int J Urol; 2004 Nov; 11(11):973-7. PubMed ID: 15509200
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study.
Kennelly MJ; Lemack GE; Foote JE; Trop CS
Urology; 2009 Oct; 74(4):741-5. PubMed ID: 19628264
[TBL] [Abstract][Full Text] [Related]
5. Streamlining risk stratification in infants and young children with spinal dysraphism: Vesicoureteral reflux and/or bladder trabeculations outperforms other urodynamic findings for predicting adverse outcomes.
Timberlake MD; Jacobs MA; Kern AJ; Adams R; Walker C; Schlomer BJ
J Pediatr Urol; 2018 Aug; 14(4):319.e1-319.e7. PubMed ID: 30253979
[TBL] [Abstract][Full Text] [Related]
6. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
[TBL] [Abstract][Full Text] [Related]
7. Change in urodynamic pattern and incidence of urinary tract infection in patients with traumatic spinal cord injury practicing clean self-intermittent catheterization.
Neyaz O; Srikumar V; Equebal A; Biswas A
J Spinal Cord Med; 2020 May; 43(3):347-352. PubMed ID: 30277852
[No Abstract] [Full Text] [Related]
8. Spinal cord injury in children: long-term urodynamic and urological outcomes.
Generao SE; Dall'era JP; Stone AR; Kurzrock EA
J Urol; 2004 Sep; 172(3):1092-4, discussion 1094. PubMed ID: 15311046
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for febrile genito-urinary infection in the catheterized patients by with spinal cord injury-associated chronic neurogenic lower urinary tract dysfunction evaluated by urodynamic study and cystography: a retrospective study.
Shigemura K; Kitagawa K; Nomi M; Yanagiuchi A; Sengoku A; Fujisawa M
World J Urol; 2020 Mar; 38(3):733-740. PubMed ID: 30949801
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
[TBL] [Abstract][Full Text] [Related]
11. Differences in bladder compliance with time and associations of bladder management with compliance in spinal cord injured patients.
Weld KJ; Graney MJ; Dmochowski RR
J Urol; 2000 Apr; 163(4):1228-33. PubMed ID: 10737503
[TBL] [Abstract][Full Text] [Related]
12. Effects of intravesical electrical stimulation therapy on urodynamic patterns for children with spina bifida: a 10-year experience.
Choi EK; Hong CH; Kim MJ; Im YJ; Jung HJ; Han SW
J Pediatr Urol; 2013 Dec; 9(6 Pt A):798-803. PubMed ID: 23177928
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.
Franco I; Horowitz M; Grady R; Adams RC; de Jong TP; Lindert K; Albrecht D
J Urol; 2005 Jan; 173(1):221-5. PubMed ID: 15592080
[TBL] [Abstract][Full Text] [Related]
14. [Effect of intermittent catheterization on urinary tract infections and incontinence in children with spina bifida].
van Gool JD; de Jong TP; Boemers TM
Monatsschr Kinderheilkd; 1991 Sep; 139(9):592-6. PubMed ID: 1745248
[TBL] [Abstract][Full Text] [Related]
15. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
Stöhrer M; Mürtz G; Kramer G; Schnabel F; Arnold EP; Wyndaele JJ;
Eur Urol; 2007 Jan; 51(1):235-42. PubMed ID: 16698176
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.
Gamé X; Castel-Lacanal E; Bentaleb Y; Thiry-Escudié I; De Boissezon X; Malavaud B; Marque P; Rischmann P
Eur Urol; 2008 Mar; 53(3):613-8. PubMed ID: 17804150
[TBL] [Abstract][Full Text] [Related]
17. Urodynamic findings in young men with chronic lower urinary tract symptoms.
Karami H; Valipour R; Lotfi B; Mokhtarpour H; Razi A
Neurourol Urodyn; 2011 Nov; 30(8):1580-5. PubMed ID: 21780163
[TBL] [Abstract][Full Text] [Related]
18. [The consequence after introduction of clean intermittent catheterization (CIC) in children with neurogenic bladder dysfunction secondary to spina bifida--the comparison of patients with and without upper urinary tract dilation at the time CIC was introduced].
Obara K; Komeyama T; Mizusawa T; Tsutsui T; Wakatsuki H; Arai K; Kosegawa E; Suzuki K; Takahashi K
Nihon Hinyokika Gakkai Zasshi; 2003 Nov; 94(7):664-70. PubMed ID: 14671996
[TBL] [Abstract][Full Text] [Related]
19. Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study.
Madersbacher H; Mürtz G; Alloussi S; Domurath B; Henne T; Körner I; Niedeggen A; Nounla J; Pannek J; Schulte-Baukloh H; Schultz-Lampel D; Bock P; Strugala G
BJU Int; 2009 Mar; 103(6):776-81. PubMed ID: 19007380
[TBL] [Abstract][Full Text] [Related]
20. The management of paediatric neurogenic bladder: an approach in a resource-poor setting.
Maison POM; Lazarus J
Paediatr Int Child Health; 2017 Nov; 37(4):280-285. PubMed ID: 28714784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
